Quanterix Corporation $QTRX Shares Purchased by Aberdeen Group plc

Key Points

• Aberdeen Group plc increased its stake in Quanterix Corporation by 29.9%, now owning approximately 0.69% of the company valued at $1.75 million.
• Quanterix has received several downgrades from analysts, with a consensus price target of $11.75 and a current average rating of "Hold".
• Insiders have been actively purchasing shares, with Director William P. Donnelly increasing his position by 202.5% after acquiring 93,113 shares at $5.44 each.

Aberdeen Group plc grew its stake in shares of Quanterix Corporation (NASDAQ:QTRX - Free Report) by 29.9% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 268,717 shares of the company's stock after purchasing an additional 61,794 shares during the period. Aberdeen Group plc owned approximately 0.69% of Quanterix worth $1,749,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Geode Capital Management LLC grew its position in shares of Quanterix by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 863,503 shares of the company's stock valued at $9,181,000 after acquiring an additional 4,836 shares during the period. Envestnet Asset Management Inc. grew its holdings in shares of Quanterix by 22.5% during the 4th quarter. Envestnet Asset Management Inc. now owns 342,264 shares of the company's stock valued at $3,638,000 after purchasing an additional 62,757 shares during the last quarter. Invesco Ltd. grew its holdings in Quanterix by 16.3% in the 4th quarter. Invesco Ltd. now owns 33,654 shares of the company's stock worth $358,000 after acquiring an additional 4,729 shares during the last quarter. Raymond James Financial Inc. bought a new stake in Quanterix in the 4th quarter worth $570,000. Finally, XTX Topco Ltd bought a new stake in shares of Quanterix during the 4th quarter valued at about $164,000. Institutional investors and hedge funds own 86.48% of the company's stock.

Wall Street Analyst Weigh In

QTRX has been the subject of a number of analyst reports. Leerink Partners reaffirmed a "market perform" rating and set a $8.00 price objective (down previously from $12.00) on shares of Quanterix in a research report on Wednesday, April 30th. Leerink Partnrs cut shares of Quanterix from a "strong-buy" rating to a "hold" rating in a report on Wednesday, April 30th. Wall Street Zen cut shares of Quanterix from a "hold" rating to a "sell" rating in a research note on Thursday, May 22nd. Finally, Canaccord Genuity Group reissued a "hold" rating and issued a $5.00 price objective (down from $12.00) on shares of Quanterix in a research note on Monday, August 11th. One research analyst has rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. Based on data from MarketBeat, Quanterix has a consensus rating of "Hold" and an average target price of $11.75.

Insider Activity

In other news, Director William P. Donnelly purchased 93,113 shares of the stock in a transaction dated Friday, June 6th. The shares were purchased at an average price of $5.44 per share, with a total value of $506,534.72. Following the transaction, the director owned 139,094 shares in the company, valued at $756,671.36. The trade was a 202.50% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director David R. Walt purchased 131,869 shares of the business's stock in a transaction on Friday, June 6th. The shares were acquired at an average price of $5.43 per share, for a total transaction of $716,048.67. Following the completion of the purchase, the director directly owned 1,628,802 shares of the company's stock, valued at approximately $8,844,394.86. This trade represents a 8.81% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders have bought 463,113 shares of company stock worth $2,625,444. Corporate insiders own 6.90% of the company's stock.

Quanterix Stock Down 0.2%

NASDAQ:QTRX traded down $0.01 during trading hours on Friday, hitting $4.83. 984,933 shares of the company were exchanged, compared to its average volume of 835,961. Quanterix Corporation has a 52-week low of $4.05 and a 52-week high of $15.85. The company's 50 day moving average price is $5.79 and its 200-day moving average price is $6.07.

Quanterix (NASDAQ:QTRX - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported ($0.47) EPS for the quarter, missing the consensus estimate of ($0.41) by ($0.06). Quanterix had a negative return on equity of 18.41% and a negative net margin of 56.04%.The company had revenue of $24.48 million for the quarter, compared to analyst estimates of $29.73 million. Quanterix has set its FY 2025 guidance at EPS. Analysts anticipate that Quanterix Corporation will post -0.98 EPS for the current year.

About Quanterix

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.